Kentucky Retirement Systems bought a new stake in Mylan NV (NASDAQ:MYL) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 22,429 shares of the company’s stock, valued at approximately $615,000.
Several other large investors also recently made changes to their positions in the company. Kinneret Advisory LLC purchased a new position in shares of Mylan during the fourth quarter valued at approximately $71,000. First Hawaiian Bank increased its position in shares of Mylan by 560.4% during the fourth quarter. First Hawaiian Bank now owns 2,886 shares of the company’s stock valued at $79,000 after acquiring an additional 2,449 shares in the last quarter. NuWave Investment Management LLC increased its position in shares of Mylan by 18.1% during the fourth quarter. NuWave Investment Management LLC now owns 3,136 shares of the company’s stock valued at $86,000 after acquiring an additional 480 shares in the last quarter. FNY Investment Advisers LLC increased its position in shares of Mylan by 42.8% during the fourth quarter. FNY Investment Advisers LLC now owns 3,300 shares of the company’s stock valued at $90,000 after acquiring an additional 989 shares in the last quarter. Finally, Fort L.P. bought a new stake in shares of Mylan during the fourth quarter valued at approximately $92,000. 83.68% of the stock is currently owned by hedge funds and other institutional investors.
In other Mylan news, insider Paul Campbell sold 11,533 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $27.50, for a total value of $317,157.50. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.81% of the company’s stock.
Mylan stock opened at $26.93 on Tuesday. Mylan NV has a twelve month low of $26.00 and a twelve month high of $42.50. The company has a debt-to-equity ratio of 1.17, a quick ratio of 0.83 and a current ratio of 1.39. The stock has a market capitalization of $13.92 billion, a PE ratio of 5.88, a price-to-earnings-growth ratio of 1.13 and a beta of 1.48.
Mylan (NASDAQ:MYL) last posted its earnings results on Tuesday, February 26th. The company reported $1.30 earnings per share for the quarter, missing analysts’ consensus estimates of $1.36 by ($0.06). The business had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.10 billion. Mylan had a return on equity of 19.06% and a net margin of 3.08%. The business’s quarterly revenue was down 4.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.43 earnings per share. On average, equities analysts forecast that Mylan NV will post 4.38 earnings per share for the current fiscal year.
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS.
Featured Story: Leveraged Buyout (LBO) Explained
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.